Reply: Comment on the Article by Loeser et al

Richard F. Loeser; John A. Collins; Brian O. Diekman; Cathy S. Carlson

doi:10.1002/art.41431

Reply: Comment on the Article by Loeser et al

Richard F. Loeser, John A. Collins, Brian O. Diekman, Cathy S. Carlson

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2162-2163
Number of pages	2
Journal	Arthritis and Rheumatology
Volume	72
Issue number	12
DOIs	https://doi.org/10.1002/art.41431
State	Published - Dec 2020

Bibliographical note

Funding Information:
Supported by the NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases grant AR‐049003 and National Institute on Aging grant AG‐044034). Dr. Loeser has received consulting fees from Unity Biotechnology (less than $10,000). No other disclosures relevant to this letter were reported.

Publisher link

10.1002/art.41431

Find It

Find It at U of M Libraries

Cite this

@article{3f248079b4b5497db266fd62ff2a592b,

title = "Reply: Comment on the Article by Loeser et al",

author = "Loeser, {Richard F.} and Collins, {John A.} and Diekman, {Brian O.} and Carlson, {Cathy S.}",

note = "Funding Information: Supported by the NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases grant AR‐049003 and National Institute on Aging grant AG‐044034). Dr. Loeser has received consulting fees from Unity Biotechnology (less than $10,000). No other disclosures relevant to this letter were reported.",

year = "2020",

month = dec,

doi = "10.1002/art.41431",

language = "English (US)",

volume = "72",

pages = "2162--2163",

journal = "Arthritis and Rheumatology",

issn = "2326-5191",

publisher = "John Wiley and Sons Ltd",

number = "12",

}

TY - JOUR

T1 - Reply

T2 - Comment on the Article by Loeser et al

AU - Loeser, Richard F.

AU - Collins, John A.

AU - Diekman, Brian O.

AU - Carlson, Cathy S.

N1 - Funding Information: Supported by the NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases grant AR‐049003 and National Institute on Aging grant AG‐044034). Dr. Loeser has received consulting fees from Unity Biotechnology (less than $10,000). No other disclosures relevant to this letter were reported.

PY - 2020/12

Y1 - 2020/12

UR - http://www.scopus.com/inward/record.url?scp=85091689955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091689955&partnerID=8YFLogxK

U2 - 10.1002/art.41431

DO - 10.1002/art.41431

M3 - Letter

C2 - 33459503

AN - SCOPUS:85091689955

SN - 2326-5191

VL - 72

SP - 2162

EP - 2163

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

IS - 12

ER -

Reply: Comment on the Article by Loeser et al

Bibliographical note

Publisher link

Find It

Other files and links

Cite this